Andrew Koustenis
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Cancer Research top 10%
- Genetics top 10%
- Molecular Biology
- Co-authors
- Sara M. TolaneyMaura N. DicklerVéronique DièrasJavier CortésDebra A. PattJosé BaselgaHans WildiersHope S. Rugo
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Lung Cancer Research Studies (12 papers)Advanced Breast Cancer Therapies (9 papers)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Andrew Koustenis
30 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 758
- Oncology 686
- Cancer Research 204
- Genetics 151
- Molecular Biology 138
Countries citing papers authored by Andrew Koustenis
This map shows the geographic impact of Andrew Koustenis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Koustenis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Koustenis more than expected).
Fields of papers citing papers by Andrew Koustenis
This network shows the impact of papers produced by Andrew Koustenis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Koustenis. The network helps show where Andrew Koustenis may publish in the future.
Co-authorship network of co-authors of Andrew Koustenis
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Koustenis. A scholar is included among the top collaborators of Andrew Koustenis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Koustenis. Andrew Koustenis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 16 | |
| 4 | 9 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancerbreakdown → | 490 |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 134 | |
| 12 | 4 | |
| 13 | 52 | |
| 14 | 44 | |
| 15 | 120 | |
| 16 | 12 | |
| 17 | 27 | |
| 18 | 26 | |
| 19 | 28 | |
| 20 | 5 |
About Andrew Koustenis
Andrew Koustenis is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (12 papers) and Advanced Breast Cancer Therapies (9 papers). The work is most often cited by research in Oncology (686 citations), Pulmonary and Respiratory Medicine (758 citations) and Genetics (151 citations). Andrew Koustenis has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Sara M. Tolaney, Maura N. Dickler, Véronique Dièras, Javier Cortés, Debra A. Patt, José Baselga, Hans Wildiers, Hope S. Rugo, Martin Frenzel and Clifford A. Hudis. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.